A drug to treat inflammation plays a surprising role reducing the level of infection caused by an opportunistic bug that is deadly for AIDS and cancer patients and others with weakened immune systems. The drug, sulfasalazine, spurs the body to get rid of the bug that causes Pneumocystis pneumonia by enhancing its ability to chew up the bug instead of leaving the debris to litter the lungs, where it would provoke more inflammation.